List of SBIR/STTR awards granted to Affinergy
AffinergyName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Affinergy in January, 2020 for $299,778.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS115201-01 | Phase I | 299,778 | January 15, 2020 | |||||||
A SBIR Phase I contract was awarded to Affinergy in April, 2018 for $299,617.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL142308-01 | Phase I | 299,617 | April 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Affinergy in May, 2019 for $1,461,619.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI148062-01 | Phase II | 1,461,619 | May 21, 2019 | |||||||
A SBIR Phase II contract was awarded to Affinergy in May, 2020 for $590,249.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44DK118994-02 | Phase II | 590,249 | May 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Affinergy in September, 2019 for $297,440.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL149446-01 | Phase I | 297,440 | September 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Affinergy in July, 2021 for $685,035.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44MD016365-01 | Phase II | 685,035 | July 1, 2021 | |||||||
A SBIR Phase I contract was awarded to Affinergy in March, 2019 for $320,058.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DA046998-01 | Phase I | 320,058 | March 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Affinergy in May, 2019 for $283,225.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK118994-01A1 | Phase I | 283,225 | May 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Affinergy in June, 2020 for $299,802.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL150911-01 | Phase I | 299,802 | June 20, 2020 | |||||||
A SBIR Phase I contract was awarded to Affinergy in May, 2018 for $299,244.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI138631-01 | Phase I | 299,244 | May 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Affinergy in August, 2019 for $1,493,435.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AI140931-02 | Phase II | 1,493,435 | August 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Affinergy in June, 2018 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI140931-01 | Phase I | 300,000 | June 15, 2018 | |||||||
A SBIR Phase I contract was awarded to Affinergy in September, 2018 for $320,013.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43MD013402-01 | Phase I | 320,013 | September 18, 2018 | |||||||
A SBIR Phase I contract was awarded to Affinergy in April, 2021 for $294,541.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI155250-01A1 | Phase I | 294,541 | April 2, 2021 | |||||||
A SBIR Phase II contract was awarded to Affinergy in September, 2018 for $2,276,571.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44EB024288-03 | Phase II | 2,276,571 | September 24, 2018 | |||||||
A SBIR Phase II contract was awarded to Affinergy in August, 2017 for $1,496,190.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AR066997-02A1 | Phase II | 1,496,190 | August 3, 2017 | |||||||
A SBIR Phase II contract was awarded to Affinergy in August, 2023 for $613,787.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK136390-01 | Phase II | 613,787 | August 1, 2023 |
